AstraZeneca Hits a Record High, Becomes UK’s Largest Stock

Shares of AstraZeneca climbed past their September 2024 peak on Tuesday, reaching a fresh record high and securing the company’s position as the largest UK‑listed stock by market value. The surge follows the pharmaceutical giant’s strong quarterly earnings and an October U.S. drug‑pricing deal that helped ease policy uncertainty—the U.S. makes up over 40% of the company’s sales. By 08:32 GMT the stock was up approximately 2.5%, having reached as high as £134.6, giving AstraZeneca a market value approaching £210 billion (≈ $282 billion). #PharmaStocks #UKMarkets #AstraZeneca #DrugPricing #SlimScan #GrowthStocks #CANSLIM